Additionally, relapsed patients who failed to respond to blinatumomab exhibited increased expression of PD-1 and TIM-3 on T cells, alongside elevated PD-L1 on B-ALL blasts (71, 72). Here, HAVCR2 is linked to acute lymphoblastic leukemia.